Maier, Sheila http://orcid.org/0000-0002-5173-4245
Wieland, Amanda
Cree-Green, Melanie http://orcid.org/0000-0003-1593-1695
Nadeau, Kristen http://orcid.org/0000-0002-0477-3356
Sullivan, Shelby http://orcid.org/0000-0001-8550-0220
Lanaspa, Miguel A. http://orcid.org/0000-0002-1163-1831
Johnson, Richard J. http://orcid.org/0000-0003-3312-8193
Jensen, Thomas
Article History
Accepted: 15 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: SM, AW, MCG, KN, SS, and TJ have no conflicts of interest to report. RJ and ML have equity with Colorado Research Partners LLC that is developing inhibitors of fructose metabolism. RJ also has equity with XORTX Therapeutics that is developing novel xanthine oxidase inhibitors. RJ also has consulted for Astra Zeneca and Horizon Pharma. RJ and ML are inventors on several patents and patent applications related to fructose metabolism.